id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-4020-0003,FDA,FDA-2015-E-4020,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-12-17T05:00:00Z,2015,12,2015-12-17T05:00:00Z,,2015-12-17T16:12:48Z,,0,0,0900006481db7910
FDA-2015-E-4020-0002,FDA,FDA-2015-E-4020,Letter from the U.S. Patent and Trademark Office to FDA,Other,Letter(s),2015-11-02T05:00:00Z,2015,11,2015-11-02T05:00:00Z,,2015-11-02T17:05:29Z,,0,0,0900006481d03bb8
FDA-2015-E-4020-0001,FDA,FDA-2015-E-4020,Patent Extension Application from Boehringer Ingelheim Corporation (on behalf of Boehringer Ingelheim Pharma GmbH & KG.),Other,Application,2015-11-02T05:00:00Z,2015,11,2015-11-02T05:00:00Z,,2015-11-02T17:04:22Z,,0,0,0900006481d03bb7